✦ LIBER ✦

Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial

✍ Scribed by Argiris, A.; Ghebremichael, M.; Gilbert, J.; Lee, J.-W.; Sachidanandam, K.; Kolesar, J. M.; Burtness, B.; Forastiere, A. A.

Book ID: 119996232
Publisher: American Society of Clinical Oncology
Year: 2013
Tongue: English
Weight: 328 KB
Volume: 31
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2012.45.4272

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel and irinotecan in recurrent or

Docetaxel and irinotecan in recurrent or metastatic head and neck cancer : A phase 2 trial of the Eastern Cooperative Oncology Group

✍ Athanassios Argiris; Ashley Buchanan; Bruce Brockstein; Jill Kolesar; Musie Gheb 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 2 views

Prognostic significance of human papillo

Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials

✍ Argiris, A.; Li, S.; Ghebremichael, M.; Egloff, A. M.; Wang, L.; Forastiere, A. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 207 KB

A randomized phase III trial of paclitax

A randomized phase III trial of paclitaxel with or without bevacizumab as first-line therapy for locally recurrent or metastatic breast cancer: Eastern cooperative oncology group trial E2100

✍ R. Zon; Miller; M. Wang; J. Gralow; M. Dickler; M. Cobleigh; E. Perez; T. Shenki 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Prognostic factors and long-term survivo

Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck : An analysis of two Eastern Cooperative Oncology Group randomized trials

✍ Athanassios Argiris; Yi Li; Arlene Forastiere 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 2 views

Randomized, Double-Blind, Placebo-Contro

Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401

✍ Kelly, W. K.; Halabi, S.; Carducci, M.; George, D.; Mahoney, J. F.; Stadler, W. 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 190 KB

Phase II trial of pegylated liposomal do

Phase II trial of pegylated liposomal doxorubicin plus docetaxel with and without trastuzumab in metastatic breast cancer: Eastern Cooperative Oncology Group Trial E3198

✍ Antonio C. Wolff; Molin Wang; Hailun Li; Michael R. Pins; Florence J. Pretorius; 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 311 KB